Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma
- PMID: 24048807
- DOI: 10.1002/cncr.25784
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma
Comment on
-
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.Cancer. 2010 Sep 15;116(18):4283-90. doi: 10.1002/cncr.25278. Cancer. 2010. PMID: 20564149
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources